ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000221.1|Erdacin_1 # 102 # 965 # -1 # ID=1_1;partial=00;start_type=TTG;rbs_motif=AGG;rbs_spacer=4bp;gc_cont=0.769	BGC0000221.1|Erdacin_1 	102	965	-	Loose	275	27.335	AAC(6')-Il	39.13	3004635	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	TTGAGCCGGACTCGAACGCGGGCAGGGCGCGGCACGAGCGGGCGGGTGGGAGGCGGCGCTGCCGCGCACGCGGAAATCCCCAGGCGCTCCGGTGGGGCGGGGTGTTGGATGATCGTCATGCTGACGCGACTCGAGAGCTATTACGACGCCGTCCCGCGCTCCGCCGCCCGTGCGGAGGAGTTCGGGCCGCTGACCCTCTTCGTCCGGGAGGGGGAGGGCTGGCCGTACTACGCGCGACCCTCGCTGGGGTACGCCGGGGAGGTGACGGTCGCCGACGTGGACCGGGTACGGGCGCGGCAGCGGGAGCTGGGGGTGCCCGAGGCGTTCGAGTGGGTGGCGGAGACGACGCCGGGGCTGCGGGCCGCCGTCGAGGAGAGCGGGCTCGTGGTGAGCGAGCACCCGCTGATGGTGCTGGACGGCGAGGGTGTGCCGGCCGCCGCGCCCGAGGGTGTCACCGTACGGATGGTCGGCGCCGACGATCCGGTCCTGCCGAGCGCGGCCGCCGCGCCGTACGCGGCCTTCGGCGTCGCGCCGTCGCCGGGCGCGGCCGCCCAGGTCGCCGCCAGGATCACGGCGGGGCTCACGCGCCTGGCCGCCGCCCTGGACGCGGACGGCACGGCGCTGTGCGCGGGTCAGCACCAGCCGGTCGGCGCGGTCTCGGAGGTCGTCGGGGTCGGCACGCTTCCGGCCGCTCGCCGCCGCGGTCTGGGCCTGGCCGTGACCGCCGCCCTGGTCGCGGACGCCCGGGCGCGGGGCGTGGAGACGGTCTTCCTGACGGCCACGGACGGTGACGTGGCCCGGCTGTACGGCCGGCTGGGGTTCCGTACGGCGGGGACGGGTCTGATCGCCGAACCCGCCTCCTGA	MSRTRTRAGRGTSGRVGGGAAAHAEIPRRSGGAGCWMIVMLTRLESYYDAVPRSAARAEEFGPLTLFVREGEGWPYYARPSLGYAGEVTVADVDRVRARQRELGVPEAFEWVAETTPGLRAAVEESGLVVSEHPLMVLDGEGVPAAAPEGVTVRMVGADDPVLPSAAAAPYAAFGVAPSPGAAAQVAARITAGLTRLAAALDADGTALCAGQHQPVGAVSEVVGVGTLPAARRRGLGLAVTAALVADARARGVETVFLTATDGDVARLYGRLGFRTAGTGLIAEPAS	MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVARPAAVLIAVAPDGEALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFASDTQLTNSASTSAHLAAGFTEVAQVRCFRKPL	188.82	gnl|BL_ORD_ID|2117|hsp_num:0	3334			237	372	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000221.1|Erdacin_2 # 1034 # 2302 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.715	BGC0000221.1|Erdacin_2 	1034	2302	+	Loose	750	172.17	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	33.54	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGAACCGCCGCGTCGTCATCACCGGGATCGGTGTCCGCACGCCGGGCGGCGCCGGGACGAAGGAGTTCTGGGGGCTGCTGTCGGAAGGGCGTACGGCCACCCGTTCCATCTCCTTCTTCGACGCCTCACCCTTCCGCTCCAGGATCGCCGGCGAGGTCGACTTCGACGCCCGCGCGGAGGGCCTGAGCCCCCGCGAGATCCGCCGGATGGACCGCGCCACCCAGTTCGCCGTGGTCTGCGCGCGCGACGCGGTCGCCGACAGCGGCCTGGAGATCGGCTCGCTCGACCCGTACCGCGTCGGCGTCAGCCTCGGCAGCGCCGTCGCCTCCGCGACCAGCCTGGAGAACGAGTACCTGGTCATGTCGGACGCGGGCAAGGAGTGGGTGGTCGACCCCGGCTACCTCTCGCCGCACATGTTCGACTACCTCAGCCCCGGCGTGATGCCGGCCGAAGTCGCCTGGACCGTCGGCGCCGAGGGACCGGTGACCATGGTCTCCGACGGCTGCACCTCCGGACTCGACGCCGTCGGCTACGGCGTGCAGCTCATCCGCGAGGGCACGGTCGACACGGTCCTCGCCGGAGCGTCCGACACCCCCATCTCGCCGATCGTCGTCGCCTGCTTCGACGCCATCAAGGCGACCACCCCGCGCAACGACGACCCCGCCCACGCCTCCCGGCCCTTCGACGGCTCGCGCAACGGCTTCGTCCTCGCCGAGGGCGCGGCCATGTTCGTCCTGGAGGAGTACGAGTCGGCCAAGCGGCGCGGCGCGCACATCTACGCCGAGATCGGCGGCTACGCCACCCGCTGCAACGCCCACCACATGACCGGGCTCAAGAAGGACGGCCGCGAGATGGCGGAGGCGATCCGCGTCGCGCTCGACGAGGCGCGCCTCGACGGCACCGTCATCGACTACATCAACGCCCACGGCTCCGGCACCAAGCAGAACGACCGGCACGAGACGGCCGCGTTCAAGCGCAGCCTCGGCCAGCACGCCTACGACGTGCCGGTCAGCTCCATCAAGTCGATGGTCGGGCACTCGCTCGGCGCGATCGGCTCCATCGAGATCGCCGCGTCCGCGCTGGCGATCGAGCACGGCGTCGTCCCGCCCACCGCCAACCTGCACACGCCCGACCCGGAGTGCGACCTCGACTACGTGCCGCTGACGGCGCGCGAGCAGCGGGTCGACACCGTCCTGTCGGTGGGCAGCGGCTTCGGCGGCTTCCAGAGCGCGATGGTGCTGCACCGACCGGAGGTGGCGGGCCGATGA	MNRRVVITGIGVRTPGGAGTKEFWGLLSEGRTATRSISFFDASPFRSRIAGEVDFDARAEGLSPREIRRMDRATQFAVVCARDAVADSGLEIGSLDPYRVGVSLGSAVASATSLENEYLVMSDAGKEWVVDPGYLSPHMFDYLSPGVMPAEVAWTVGAEGPVTMVSDGCTSGLDAVGYGVQLIREGTVDTVLAGASDTPISPIVVACFDAIKATTPRNDDPAHASRPFDGSRNGFVLAEGAAMFVLEEYESAKRRGAHIYAEIGGYATRCNAHHMTGLKKDGREMAEAIRVALDEARLDGTVIDYINAHGSGTKQNDRHETAAFKRSLGQHAYDVPVSSIKSMVGHSLGAIGSIEIAASALAIEHGVVPPTANLHTPDPECDLDYVPLTAREQRVDTVLSVGSGFGGFQSAMVLHRPEVAGR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			306	1245	isoniazid
BGC0000221.1|Erdacin_3 # 2299 # 3522 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.734	BGC0000221.1|Erdacin_3 	2299	3522	+	Loose	1700	25.7942	AxyY	33.33	3004144	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; cephalosporin	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCGCACGTACCGTGGTCACCGGGGTGGCGGTCGCCGCGCCCGGCGGCCTGGGAGCCGAGGAGTACTGGAAGTCGGCGCTCACCGGGAACAGCGGAATCTCCGAGCTCACCCGGTTCGACACCACCGCCTTCCCGTCCCGGCTCGCCGGACAGATCCTCGACTTCGAGGCGAAGGACCATCTGCCGAGCCGGCTGCTGCCGCAGACGGACGTCTCCACCCGCTACGCCCTGGCGGCCGCCGACTGGGCGCTGGCGGACGCGGCCGTCACCCTCGACACCCTGCCCGACTACGAGATGGGTGTGGTGACGGCCAACGCGCTCGGCGGATTCGACTTCACCCACCAGGAGTTCCAGAAACTGTGGGCCCAAGGGCCGGAGTTCGTCTCGGTGTACGAGTCGTTCGCCTGGTTCTACGCCGTCAACACCGGCCAGATCTCCATCCGCAACGCGATGCGCGGACCCAGCGCGGCCCTGGTCGCGGAGCAGGCCGGCGGGCTGGACGCGATCGGCCACGCCCGCCGTACGATCGCGAGCGGCACCAGGCTGGTGCTCAGCGGCGGCGTCGACTCCGCCTTCGACCCGTGGGGCTGGGCCTCCCAGCTCGCCGGCGGCCTGGTCTCCACGTCCGACGACCCGGCGCGCGCCTATCTGCCCTTCGACGTCCACGCCCGCGGCCATGTGCCGGGCGAGGGCGGGGCGATCCTCATCGTCGAGGACGCCTCGTCGGCCGCCGAACGGGGCGCCCCGAAGGTGTACGGCGAGATCGCCGGGTACGCCGCGACCTTCGACCCGGCCCCCGGCTCGGGCCGCCCGCCCGGCCTGCGCCGGGCGGCCGAACTCGCCCTCGCCCAGGCCGGGGTGACACCCGCCGACGTGGACGTGGTGTACGCCGACGCGGCCGGAGTCCCCGAGCTCGACCGGATCGAGGCCGAGGCGATCACCGGCGTCTTCGGGCCGCGCGCAGTCCCGGTCACCGCACCCAAGACGCTCACCGGCCGGATGTACTCGGGCGGCGGACCCGTCGACGTGGTCGCGGCCCTGATGTCGATCCGCGACCAGGTGGTGCCCGGCACCGCCGGCACCACGGAGGTGCCGGAGGAGTACGGCCTCGACCTGGTGTTCGGCGAACCGCGCGAACTGCCGGTCACCACCGTGCTCGTGCTGGCCCGCGGCCGCTGGGGCTTCAACTCCGCCCTGGTCGTCACCGCCCCCACCCCCTGA	MSARTVVTGVAVAAPGGLGAEEYWKSALTGNSGISELTRFDTTAFPSRLAGQILDFEAKDHLPSRLLPQTDVSTRYALAAADWALADAAVTLDTLPDYEMGVVTANALGGFDFTHQEFQKLWAQGPEFVSVYESFAWFYAVNTGQISIRNAMRGPSAALVAEQAGGLDAIGHARRTIASGTRLVLSGGVDSAFDPWGWASQLAGGLVSTSDDPARAYLPFDVHARGHVPGEGGAILIVEDASSAAERGAPKVYGEIAGYAATFDPAPGSGRPPGLRRAAELALAQAGVTPADVDVVYADAAGVPELDRIEAEAITGVFGPRAVPVTAPKTLTGRMYSGGGPVDVVAALMSIRDQVVPGTAGTTEVPEEYGLDLVFGEPRELPVTTVLVLARGRWGFNSALVVTAPTP	MARFFIDRPVFAWVISLLIALVGLLSIRALPVAQYPDIAPPVVNIGASYPGASAKVVEEAVTAIIEREMNGAPGLMYTSSSSDSTGWASINLTFKQGTNPDIAAVEVQNRLKAVEPRLPESVRRDGVRVEKAADNIQLVVSLKSDGSLDDMQLGELAASNVLQALRRVEGVGKVQSFGAEAAMRIWPDPAKLTALSLTPGDIVSALRSHNARVTIGELGNQAVPKDAPLNASIVAGESLHTPEQFANIPLRALPDGATLRLKDVARVELGGTDYMYLSRVNGLTGTGLGIKLAPGSNAVETTRRIRETMRELAQYFPPGVTWDIPYETSTFVEISIKKVLMTLLEAVALVFCVMYLFMQNLRATLIPTLVVPVALLGTLGVMLGLGYSINVLTMFGMVLAIGILVDDAIVVVENVERIMAEEGLSPHDATVKAMGQISGAIVGITVVLVSVFVPMAFFDGAVGNIYRQFAVTLAVSIAFSAFLALSLTPALCASLLKPVPAGHHEKRGFFGWFNRAFARLTTRYTARVAGVLARPVRFGLAYALVIGVAALLFARLPSSFLPDEDQGSFMAMVILPQGSPQAETMAVVKDVERYMMEHEPVQYVYSVNGFSQYGSGPNSAMFFVTLKDWKERRDASQHVDAVVKRINKAFADRKNLMVFALNSPPLPDLGSTSGFDFRLQDRGGLGYEALTQARQKLLAKAAEHPALTDVVFAGQEEAPQLQLRVDRDKAQAMGVPIDEINTALAVMYGSDYIGDFMLNGQVRRVMVQADGKRRVDVDDISRLHVRNLQGQMVPLSAFATLTWSMGPPQLNRYNGFPSFTINGSAARGHSSGEAMRAMETLAAELPRGIGFDWSGQSYEERLSGNQAPVLFALSVLIVFLALAALYESWSIPLAVILVVPLGVIGALLGVTVRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVRDGQGILSATLEAARLRLRPIVMTSLAFGVGVLPLALATGAASGAQAAIGTGVLGGIITATVLAVFLVPLFFLIVGRMVGMRARPARPDGREPLETTP	38.95	gnl|BL_ORD_ID|2411|hsp_num:0	2799			2067	2244	erythromycin; cefepime
BGC0000221.1|Erdacin_4 # 3548 # 3817 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.693	BGC0000221.1|Erdacin_4 	3548	3817	+	Loose	550	24.2534	Nocardia farcinica rox	55.0	3007210	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGACCCGGACACCCCTGATGACCCTGGACGACCTGCGCCGCATCCTCGTCGCCTGCGCGGGCGAGGACGACGGCATCGACCTCAGCGGGGACATCCTCGACCTCACCTTCGAGGACCTCGGCTACGACTCCCTCGCCCTGATGGAGAGCGCCGCCCGCATCAAGCAGGAGTACGGCGTCGACCTCAGCGACGACGACGTCGCCGAGGTCGAGACGCCCCGCGCCCTGCTCGACATCGTCAACGGCTCGGTACCCGCCACCGCGGTCTGA	MTRTPLMTLDDLRRILVACAGEDDGIDLSGDILDLTFEDLGYDSLALMESAARIKQEYGVDLSDDDVAEVETPRALLDIVNGSVPATAV	MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT	18.82	gnl|BL_ORD_ID|4834|hsp_num:0	5821			684	744	rifampin
BGC0000221.1|Erdacin_5 # 3913 # 4863 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.736	BGC0000221.1|Erdacin_5 	3913	4863	+	Loose	1900	26.1794	mexN	32.0	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCACGATCCACCGCACCGAGCACACCCTGGTCGTCGACGCCCCGCCGCGCACCCTCTACGACCTGGTCGCCGACACCACCCGCTGGCCGGCGATCTTCGGCCCCAGCGTCCACGTCCACCACCTGGAGCACGGTGAGCGCGACGAGCGCTTCGAGATCTGGGCGCAGGTCAACGGCGAGGTGGTCAGCTGGGTCTCCCGCCGCGTCCTGGACCCCGAACGGCTCTACATCGCCTTCCGGCAGGAGCGCAGCGCACCTCCGTTCGCCTCCATGAGCGGCGGCTGGCTCTTCCGCGCCCTGCCCGGAGGCCGCACCGAGGTGGTGCTGCGGCACCGGTTCGCCGCGCTCGACGAGGACCCGGCGACCCTGGAGCGGATCCACCGGGCGCTCGACCGCAACAGCCCCCAGGAGCTCGCCGCGCTCGCCCGGATCGCCCAACTCGGCACCGATGTCGAGGAGGTGGTGTTCTCCTTCACCGACACCGTGCCGCTGACCGGCACGGCGGCCGCCGCGTACGCCTTCGTCGACCGCGCCGACCTGTGGGCGGAGCGTCTCCCGCACGTCTCCCGCGCCCGTCTCACCGAGGACGTCCCGGGCATCCAGACCCTGGAGATGGACACCGTCACCGCCGACGGCAGCGCGCACCGCACCCGGTCGGTGCGCGTCTGCCGGGAGCCGAGCTGGATCGCGTACAAGCAGCTGGAGATGCCGCGGCTGCTGAGCGGGCACAGCGGGCTGTGGACCTTCACGGACGGGCCGGACGGCCCGGTCGCCGTCTCCCGGCACACGGTGGCGATCGACCCGTCGGCCGTCGAGGAGGTGCTGGGCGCGGGGGCCACGCTCGCCGACGCGCGCCGGTATCTCCGCGAGGCGCTGGGCCGCAACAGCCTGACCACGATGACGCACGCGGCGGCCTACGCGCAGGAGCACGGCAGCGCGGTGCGCTGA	MTTIHRTEHTLVVDAPPRTLYDLVADTTRWPAIFGPSVHVHHLEHGERDERFEIWAQVNGEVVSWVSRRVLDPERLYIAFRQERSAPPFASMSGGWLFRALPGGRTEVVLRHRFAALDEDPATLERIHRALDRNSPQELAALARIAQLGTDVEEVVFSFTDTVPLTGTAAAAYAFVDRADLWAERLPHVSRARLTEDVPGIQTLEMDTVTADGSAHRTRSVRVCREPSWIAYKQLEMPRLLSGHSGLWTFTDGPDGPVAVSRHTVAIDPSAVEEVLGAGATLADARRYLREALGRNSLTTMTHAAAYAQEHGSAVR	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	30.50	gnl|BL_ORD_ID|2021|hsp_num:0	2217			1209	1359	chloramphenicol; thiamphenicol
BGC0000221.1|Erdacin_6 # 4936 # 5721 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.701	BGC0000221.1|Erdacin_6 	4936	5721	-	Loose	400	26.9498	VIM-61	29.25	3005509	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	VIM beta-lactamase	ATGACAACGGCAGTCAGGCCGGTGGCCCTGGTGACCGGCGCGACCAGCGGCATCGGCCTCGAGATCACCCGGCGGCTCGCGGGGCTCGGCGCCCGGGTCTTCGTCTGCGCCCGGCAGCAGGAGCCGCTGACCACGCTGATCAAGGAGGAGCGGGACGCCGGGCACGATGTCGACGGCGTCGTCTGCGACGTCTCCGACCACAGTCAGATCAAGGCGTATGTGAAGGCGGCGGTGGACCGCTTCGGCCCGGTCGACATCCTGGTCAACAACGCCGGCCGCAGCGGCGGCGGCGCGACCGCCGAGATCCCCGACGAGCTGTGGCTCGACGTGATCAACACCAATCTCAACAGCGTCTTCCTGATGACCAAGGAGGTGCTGACGACCGGCGGCATGCTCGGCCGGGAGCGCGGACGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTGGTCCACGCCGCCCCGTACTCGGCCTCCAAGCACGGTGTCGTCGGCTTCACCAAGGCCCTCGGCCTGGAGCTCGCCCGTACCGGCATCACCGTCAACGCGGTCTGCCCCGGCTTCGTGGAGACGCCGATGGCCGAGCGGGTACGGGAGCACTACGCGTCCATCTGGGGCGTGAGCGAGCAGGAGACCCACGACCGGATCACCACCCGGGTGCCGATCGGCCGCTATGTGGAGACCCGCGAGGTCGCCGCCATGGTCGAGTACCTGGTCGGCGACGACGCCGCGGCCGTGACGGCGCAGGCGCTCAACGTCTGCGGCGGCCTGGGCAACTACTGA	MTTAVRPVALVTGATSGIGLEITRRLAGLGARVFVCARQQEPLTTLIKEERDAGHDVDGVVCDVSDHSQIKAYVKAAVDRFGPVDILVNNAGRSGGGATAEIPDELWLDVINTNLNSVFLMTKEVLTTGGMLGRERGRIISIASTGGKQGVVHAAPYSASKHGVVGFTKALGLELARTGITVNAVCPGFVETPMAERVREHYASIWGVSEQETHDRITTRVPIGRYVETREVAAMVEYLVGDDAAAVTAQALNVCGGLGNY	MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQKLGDTVYSSNGLIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGVATYTSPLTRQLAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVHEASRESAGYVADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTNVVKTHKVRPVAE	98.49	gnl|BL_ORD_ID|4639|hsp_num:0	5710			273	564	
BGC0000221.1|Erdacin_7 # 5881 # 6339 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.697	BGC0000221.1|Erdacin_7 	5881	6339	+	Loose	750	25.409	tet(33)	40.62	3000478	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGCCGAGACCGCCACCCCGGTACCGACCGGTGTACGGACCGGTCTGTACGCCCTCGTCCAGCACTTCTACGCCCGGCAGATGCAGGCGCTGGACGACGGGCGCTTCGAGGAGTACGCCGCCACCTTCACCGAGGACGGCACCTTCCAGCACACCCCGGGCACCGAACCGGCCCGCACCCGGCCCGGTATCGTCGCCGAACTCAACCGCTTCCACGAGAAGTTCGCGGACGACCCGGTGCGGCGGCGCCACTACTTCAACCAGCTCGTCCTGGACCCGCAGCCCGACGGAAGCTACCGCTCCACCGTCTACGCGCTCATCGTCCGGATCAGGCCGGGCGAGCGCCCGGAGGTCTGGCCCAGCTGCGTGGTCCACGACGTGCTCGTCGTCGACGGCGACGAGGTGGCGACTCGCTCCCGCACGGTCAGCTACGACCACCTGCCCGATGCCGTATGA	MTAETATPVPTGVRTGLYALVQHFYARQMQALDDGRFEEYAATFTEDGTFQHTPGTEPARTRPGIVAELNRFHEKFADDPVRRRHYFNQLVLDPQPDGSYRSTVYALIVRIRPGERPEVWPSCVVHDVLVVDGDEVATRSRTVSYDHLPDAV	MSSLTSARGSLATVLITASLDAAGMGLVMPILPALLHEAGVTADAVPLNVGVLIALYAVMQFIFAPVLGTLSDRFGRRRVLLVSLAGATVDYLVLATTSALSVFYIARAVAGITGATNAVTATVIADITPPHQRAKRFGLLSACYGGGMIAGPAMGGLFGAISPHLPFLLAALLSASNLALTFILLRETRPDSPARSASLAQHRGRPGLSAVPGITFLLIAFGLVQFIGQAPGATWVLFTEHRLDWSPVEVGISLSVFGIVQVLVQALLTGRIVEWIGEAKTVIIGCITDALGLVGLAIVTDAFSMAPILAALGIGGIGLPALQTLLSQRVDEQHQGRLQGVLASINSVTSIFGPVAFTTIFALTYINADGFLWLCAAALYVPCVILIMRGTAASPKFGSWASGDSM	37.35	gnl|BL_ORD_ID|1926|hsp_num:0	2046			132	225	tetracycline
BGC0000221.1|Erdacin_9 # 7294 # 8094 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.773	BGC0000221.1|Erdacin_9 	7294	8094	+	Loose	275	24.6386	AAC(6')-34	23.68	3003989	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGGCCTCTCAGGTGCCGCTCGTCCGGCCGGACGAGTCCTGGCGGGCGGTGGGCGCCGCGGTGCGCGACGACGGGCTCGCGGTGGTCGCCGGGCATCCGTCCCACTGGCCGGAGGGGGCCCGCCGGCTCGCGCTGACCGCCGCGGGCGCGGCCCTGCGGCGGCCGCCCGGCGCGCTGGAACTGGGCCGGGCCCCCGGCGGCCGGCCCTATCTGCGCGGCCACCCGGAGCTGGAGGTGAGCCTCGGCCACACCCGCGGTCTGCTGGTGGCGGCGGTGAGCGCGAGGGGCCGGGTCGGCGTCGACGTCGAGCCCGCGGGGCGCGGTGTGTACGGCACGCCGCTGGTGGCCGAGATGACGACCCCGTACGAACGAAGCGCCCTCGCCGCGCTGCCGGAGGAGGAGCGCAACGCCGCCCTCGTACGGCTGTGGACGCGCAAGGAGGCGTACACCAAGGCGCTGGGCGTGGGGCTCCGGCTGCCGTTCACGGCCTTCGGCCTGGTCCGCGGCCCGGCCGGATACGGCCCGCGGGGCCCGGACGGCCGCCCCGTGGATCCGTCCGAGCGGGACCGGTGGCGGTTCGGCACCGATCCTGATGTGGCGGGGTGCGTGGTGAGCTGGGCCGTACGTCAGCTGGCGAACGTCTCGTACGAGGAGTCCAGTTCGAGCTGCGGGGCGCCCGAGAGCACCTGCTGGTGCAGCCGCTGGAGGCGGGGCGACGGCTCGACCCCGAGCTCCTCGCGCAGCGCCGCCCGCAACTGCTGGAACGTCTCCAGCGCGCGCCACGGGTGGCCCGAGCGGTAG	MASQVPLVRPDESWRAVGAAVRDDGLAVVAGHPSHWPEGARRLALTAAGAALRRPPGALELGRAPGGRPYLRGHPELEVSLGHTRGLLVAAVSARGRVGVDVEPAGRGVYGTPLVAEMTTPYERSALAALPEEERNAALVRLWTRKEAYTKALGVGLRLPFTAFGLVRGPAGYGPRGPDGRPVDPSERDRWRFGTDPDVAGCVVSWAVRQLANVSYEESSSSCGAPESTCWCSRWRRGDGSTPSSSRSAARNCWNVSSARHGWPER	MRIGDLIREDGGIAMLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVERVREHFYVDDDETRCIIKYEGKPIGYIQFYLLDEETLGEYGYNESDADCRTFATDQFIGEPDYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQHEGELRDCWIMEYRAERK	135.03	gnl|BL_ORD_ID|2233|hsp_num:0	2525			174	402	kanamycin A
BGC0000221.1|Erdacin_10 # 7920 # 8738 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.729	BGC0000221.1|Erdacin_10 	7920	8738	-	Loose	400	39.6614	vanR gene in vanA cluster	27.27	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGTGTTGCACATCGAAGTCCTCGGCCCGCTGCATGTCGCGGTCCGGGGCGTGTCCATCGTCCCGACCGCTGGAAAACCACGCCAACTGCTGGCACTGCTCGCCCAGCACGCCGGGCACATCGTCTCCGTACCGACCCTGGTCGAGGAGATCTGGGGAGACGAGGCCCCGCGGAGCGTGTCGACCACCCTGCAGACCTATGTGCTGCAGGTACGCCGCAAGATCACCACCGCGCTCGAGCAGGTGTCCCCCGACAGCGGCGCCGACGCCAAGGACCTGCTGACCACGACGTACGGCGGCTACCGCCTCGCCGCGCCCGAACGCCCCTGCGACGCGGCCCGGTTCGAGGAGCTGGCCGGGCAGGGCGTCACCGCCCTGGAGGCGGGCGATCCCCGGCGCGCCTCCGCCGTCCTGCGCCGGGCGCTCGACCTGTGGCGCGGCCCCGCTCTCGTCGACGTGCCGGTGGGCCGGGTCCTGGAGCTGGAGGTCCTCGCCCTCGACGAGGCCAGGGCCCGGGCCCTGGAGCTGCGGATCGAGGCCGATCTTCAGCTCGGCCGGCACGCCACGCTCATCGGCGAACTGCGGGTGCTCACCGCCCGGCAGCCGCTGCACGAGGGCCACCGCGCCCAGTTGATGCTGGCGTTCTACCGCTCGGGCCACCCGTGGCGCGCGCTGGAGACGTTCCAGCAGTTGCGGGCGGCGCTGCGCGAGGAGCTCGGGGTCGAGCCGTCGCCCCGCCTCCAGCGGCTGCACCAGCAGGTGCTCTCGGGCGCCCCGCAGCTCGAACTGGACTCCTCGTACGAGACGTTCGCCAGCTGA	MVLHIEVLGPLHVAVRGVSIVPTAGKPRQLLALLAQHAGHIVSVPTLVEEIWGDEAPRSVSTTLQTYVLQVRRKITTALEQVSPDSGADAKDLLTTTYGGYRLAAPERPCDAARFEELAGQGVTALEAGDPRRASAVLRRALDLWRGPALVDVPVGRVLELEVLALDEARARALELRIEADLQLGRHATLIGELRVLTARQPLHEGHRAQLMLAFYRSGHPWRALETFQQLRAALREELGVEPSPRLQRLHQQVLSGAPQLELDSSYETFAS	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	117.75	gnl|BL_ORD_ID|750|hsp_num:0	722			456	645	vancomycin; teicoplanin
BGC0000221.1|Erdacin_11 # 8892 # 9137 # -1 # ID=1_11;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.695	BGC0000221.1|Erdacin_11 	8892	9137	-	Loose	725	23.8682	EC-16	37.04	3006877	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	EC beta-lactamase	GTGACGTTCTCCAGGAGCGACGGCCCCAGTGTCATCCGGTCGAGGGCCCGCAGCACCAGCGGGTGCGGACAGCGCAGCCGCACCGTCCCGGAGCCGCTCAGGACATGGACATCCCCTCCCGCGCCGGCCGCCCGCAGCCGGACGTCTTCCCGTAAGGACCACAACGATTTCATCGGCGACTCTTCCCGTCCTGCCGTCTCGGTCGCGGGCGGGATTCTTCCGCGCCCGTTCTCCTTTCACCAGTGA	MTFSRSDGPSVIRSRARSTSGCGQRSRTVPEPLRTWTSPPAPAARSRTSSRKDHNDFIGDSSRPAVSVAGGILPRPFSFHQ	MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGCGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ	21.49	gnl|BL_ORD_ID|3522|hsp_num:0	4591			900	978	
BGC0000221.1|Erdacin_12 # 9166 # 9543 # 1 # ID=1_12;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0000221.1|Erdacin_12 	9166	9543	+	Loose	2000	27.335	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	29.17	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	TTGCTCGTGCCGGTGCTGACCCGACTCGCCCACCTGGTGGTGCGGTCCCTCGGGCCGGAGGATCTGGGCGGGCCGCTGCTGTCGGTGGTGCCGATCGCCGACGACGCACGGTTCCGGCCAGGCTCGGCCGGGCCCGACCAACGCGTGCGGCTGGCCGCCGGGGTGGCCTTCCGGGCGGGGGAGAACGGCCCGGTGATGGTGGCCGCCGGCGGCCGCTACTGCGTCGAGATGCACCGCGCGGAGGTCTGCGAGGTGGTGCGGGTCATCGGGCGCAGGGGGTGTCTGGGAAGATCGGTACGGGCCCTTCCCACGCCTATTTCGGTGTCCTGCGAAATACTGCGTTACTTCGCCGGCACGGGAATGGTGACGATCTCCTGA	MLVPVLTRLAHLVVRSLGPEDLGGPLLSVVPIADDARFRPGSAGPDQRVRLAAGVAFRAGENGPVMVAAGGRYCVEMHRAEVCEVVRVIGRRGCLGRSVRALPTPISVSCEILRYFAGTGMVTIS	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	10.54	gnl|BL_ORD_ID|4719|hsp_num:0	2914			2910	3105	rifampin
BGC0000221.1|Erdacin_13 # 9605 # 10792 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.749	BGC0000221.1|Erdacin_13 	9605	10792	+	Loose	210	28.1054	Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline	33.33	3003378	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCGGAATTCGGGGTGGACGACAGGGCACGCCGGCCGTCGGACGGCGGACGGGACACCCGCGACTTCGCGGAATTATTCACTCCGAATCCGGTCGGCGGCTCGGAGATCGTCCTCGCGGCGGTGGTCCAGGGCCTGGTCGGCGTGTCGGGGGTGGGCTGCCTGGTCGCCGGCGGCGGCTCCGCCCCGGAGGTGCTCGGCTTCACGGCCGCCCTGCTGCTCGTCTCCTGTGTGCCGCTGGCGTACGGGCTGCTGCGGGGCCGGGGCGGGGCCCGGCCGGCGCCGCGCCACGCGCTCCTGGTCTGGAGCTCCCTGACGCTCCTGGCGCTGACCGCCGCCGTCGCGATCGCCTGGCTGGTCCGGCTGCCGCTGTGGGTGGACCTGGAGCTGACGGCGGACTGTCTGGTGGCCTGGCTGCTCTGCCACGGCCTGCTCGGGAGCGCGTCCCGGCGGCCCGATCCGGCCGGCGAACGCGGCGAGCTGCTGCGTCTGGTCACCGCGCGGGAGCGGCGGAGGTTCGGCCGGGACCTGCACGATCTGCTCGGCTACAGCCTGTCGGCCCTCACCCTCAAGGCGGAGGTGACGGAACGCTTCCTCGGGCGGGACGAGGAGCGCGCCCGGCGCGAGCTGCGGGAGATCCTCGACATCTCGCGCAAGGCCCTGGAGGAGACCCGGGCGCTGGCTGAGAGCTACCGCATGCTGTCCCTGGCCGACGAGATCGCCTCCGTACGGGAGGTGTTGAGCTCGTCCGGGATGCGGGTGACCGTCGAGGGCCCGGCCGCCCAGGGCGGCAGGACGGGCCGGCCCTGGGAGCAGGGGGCGCTCGATCACCGGGTCGGCACCCTGCTGGCCACCGTGCTGCGGGAAGGCGTCGCCAACCTGCTGCGGCACAGCAGGGCGGGCGTGTGCCGGATCCGGCTCCAGGAGGAGCGGGGCCGGATCCGGCTGACGCTGTCCAACGACGGTGCCTCGGGCGCCCGCTCCCGCCCCCGGGCGCAGGGCAGCGGCCTGGACAGCCTGGCCCGGCGGGTCGCGGAGGCGGGCGGCACCCTGTCCGCGTCGGTGGACGGCGCCGGCTGGTTTCACCTGGTGGCCGAGTGCCCCCTGCCGCCGCCGGTGCTCAGTGCAGCCACCCGGCGTCCTGGGCGATCAGAATCGCGTCCAGTCGATTGCGCGCGTGGAGCTTGA	MSEFGVDDRARRPSDGGRDTRDFAELFTPNPVGGSEIVLAAVVQGLVGVSGVGCLVAGGGSAPEVLGFTAALLLVSCVPLAYGLLRGRGGARPAPRHALLVWSSLTLLALTAAVAIAWLVRLPLWVDLELTADCLVAWLLCHGLLGSASRRPDPAGERGELLRLVTARERRRFGRDLHDLLGYSLSALTLKAEVTERFLGRDEERARRELREILDISRKALEETRALAESYRMLSLADEIASVREVLSSSGMRVTVEGPAAQGGRTGRPWEQGALDHRVGTLLATVLREGVANLLRHSRAGVCRIRLQEERGRIRLTLSNDGASGARSRPRAQGSGLDSLARRVAEAGGTLSASVDGAGWFHLVAECPLPPPVLSAATRRPGRSESRPVDCARGA	MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP	274.31	gnl|BL_ORD_ID|1984|hsp_num:0	431			243	387	tigecycline; ciprofloxacin; tetracycline; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000221.1|Erdacin_14 # 10725 # 11333 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.698	BGC0000221.1|Erdacin_14 	10725	11333	-	Loose	390	70.8626	evgA	23.83	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGATACGGCTCTTACTGGCCGAGGACATGCACATGGTCCGCGGGGCGCTGGTCGCCCTGCTTGAGCTCGAATCCGATCTGGAAGTCGTGTCCGAACTGGAGCGCGGCGACACCATCGTCGCGGAGGCACGCAGACACAAGCCCGACGTCGCCGTCATCGACATCGACCTGCCGGGCCTCGACGGACTGACCGCGGCGGAGCGACTCCATGAGGAGGTCCCGGACTGCCGCAGTCTCATCCTCACCAGCCTCGGCCGGCCCGGGACGCTGCGTCGGGCGCTGGACGCCCAGGTCGGCGGCTACCTCCTCAAGGACGCGCCGCCCGGCCAGCTCGCCGTCGCCATCAGGAAGGTCGCCGAAGGCCGGCAGGCCATCGACCCCTCACTCGCCCTGGCCGCCTGGTCCAGCGCCGAGAACCCGCTCACCCAGCGGGAGATCGACACGCTGCGGCTGGCGGCCGAGGGGGCCGGATCGTCGGAGATCGCCGACCAGCTGCATCTGGCCGTCGGCACCATCCGCAACTATCTGACGTCCGCCGTCCTCAAGCTCCACGCGCGCAATCGACTGGACGCGATTCTGATCGCCCAGGACGCCGGGTGGCTGCACTGA	MIRLLLAEDMHMVRGALVALLELESDLEVVSELERGDTIVAEARRHKPDVAVIDIDLPGLDGLTAAERLHEEVPDCRSLILTSLGRPGTLRRALDAQVGGYLLKDAPPGQLAVAIRKVAEGRQAIDPSLALAAWSSAENPLTQREIDTLRLAAEGAGSSEIADQLHLAVGTIRNYLTSAVLKLHARNRLDAILIAQDAGWLH	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	99.02	gnl|BL_ORD_ID|936|hsp_num:0	1015			18	597	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000221.1|Erdacin_15 # 11392 # 12633 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.728	BGC0000221.1|Erdacin_15 	11392	12633	-	Loose	990	67.781	qacA	29.65	3003046	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCTCAGCGGACTCGGCACCACGCGCCACACCCCGGGCGGCGGCACTCCCCGTCCTGCTGCTCGCCTCGACCCTGGCCGTGATGGCCGGGGCCATGATCACCCCCGTACTCGAGGTCATCCGCGGCGATCTCGACCTCAGCGGGACCGCCGCCGGTCTCGTCATCACCGCGCACGGTCTCGCCATCGCCGTCACCAGCCCGGTGGTCGGCCGGCTGATCGACCGCTACGGCGTGCGCGGACCGCTGGCCGGCGGACTCGTGCTGTACGGAGTCGCGGGCGCCGCCGGCCTGTTCACCGACGACTACGCCGCGCTGATCGCCGGCCGGTTCGTCTTCGGCGCCGGCGCCGCCGCCGTCTTCAGCGGTACGACGGTGGCGCTGCTCGCGCTCTACCAGGGCCCCGAGCGGGACCGGGTGATGGGCTGGCGCTCCACCGCCACCAGTCTGGGCGGGGTCGTCTGGCCGCTGATCGGCGGCGCTCTGGGCGGCCTGTCCTGGCACGCCCCGTTCGCCGTCTACCTCGTCGGCGTCCCCATCGGCCTGGCCGCGCTGTTCGTGCTGCCGGCCGGTTCCACCGGTCCGAAGGGGACCACCGGCGGCGTCCTGCCGCTGCTGCGGGAGCGCCCCGCCCTGCTCGGCTACTACGCCCTGCAGGCCGTCGCCGCCATCCTGCTGTACGGGGTGGCGGTCTTCCTGCCCCAGCGGCTCGCCCGGATCGGCGTCGAGGAGCCGTTCCTGGTCTCGCTCTACACCGTGGTGATGATGGCCGCCATGAGCCTCGTGGGGCTGGTGTACGCGAAGCTGCGCGCCGCCGCCGGCTATCCCGCCCTGCTGCGGACGGCCGCGCTGACCTGGGTGGTGTCGTTCGTCCTGCTCGGCACCGTGGACCAGCCCTGGCTGCTGCTCGTCGCCCCGATGCTGTTCGGCCTGGGGCAGGGCATCGCCTTCCCCGCCCTGACGGTGCTGGTGGGCGAGGCGGCGCCGGCCGAACGGCGGGGGCAGGCCACCTCGCTGTCCGGTACGGCCAACTTCGCCGGGCAGTTCGTCTCACCGCTGCTGCTCGGCCCGGTCGTCGCCGCGACCTCGCTCACGACCGGATTCCTCGCGGCCGCCGCGCTCTCCGCGGTGGTGTTCCTCGCCCTCCTGAGAATGCGCCACACCGAACGCCAGACCCCTCAGAACCCGCCAACATCCAAGGATGACCTGACACTTAACGCTCCCGGAACGAAATCCTCCTAG	MSSADSAPRATPRAAALPVLLLASTLAVMAGAMITPVLEVIRGDLDLSGTAAGLVITAHGLAIAVTSPVVGRLIDRYGVRGPLAGGLVLYGVAGAAGLFTDDYAALIAGRFVFGAGAAAVFSGTTVALLALYQGPERDRVMGWRSTATSLGGVVWPLIGGALGGLSWHAPFAVYLVGVPIGLAALFVLPAGSTGPKGTTGGVLPLLRERPALLGYYALQAVAAILLYGVAVFLPQRLARIGVEEPFLVSLYTVVMMAAMSLVGLVYAKLRAAAGYPALLRTAALTWVVSFVLLGTVDQPWLLLVAPMLFGLGQGIAFPALTVLVGEAAPAERRGQATSLSGTANFAGQFVSPLLLGPVVAATSLTTGFLAAAALSAVVFLALLRMRHTERQTPQNPPTSKDDLTLNAPGTKSS	MISFFTKTTDMMTSKKRWTALVVLAVSLFVVTMDMTILIMALPELVRELDPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIASSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMASVLLLASQWLQVVEELSPFKAGLYLLPMAIGDMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVGAGMASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK	80.35	gnl|BL_ORD_ID|339|hsp_num:0	372			129	633	
BGC0000221.1|Erdacin_16 # 12661 # 13695 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=6bp;gc_cont=0.765	BGC0000221.1|Erdacin_16 	12661	13695	-	Loose	2000	29.6462	Staphylococcus aureus mupB conferring resistance to mupirocin	23.85	3000510	protein homolog model	n/a	n/a	mupirocin-like antibiotic	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGACCACCACCCCGCTGCCCGTCCGCCCCCTGGGCACCACCGGCATGGACATCTCGCCCGTCGGGCTCGGCGCCTGGTCGCTGGGCGGCTCCGACTGGGGGCCCCAGGACGACGCCGACTCGATCGCCACCATCCACCGCGCCGTCGCCACCGGCGTGAACTGGATCGACACCGCCGCCGCCTACGGCCTGGGCCACTCCGAGGAGGTCATCGGCCGGGCCCTGGCCGGGCTGCCCGCTGCGGAACGCCCGTACCTCTTCACCAAGTGCGGTGTGGTCCCCGACCCGGGCGGCCTGCGCAAGGTGATGACCGCCGACAGCGTCCGGCGCGAGCTGGAGGACTCGCTGCGCCGGCTCGGCGTCGAGCACATCGACCTCTACCAGGTGCACTGGCCGGGCGACGGGCGGCTGCTCGCCTGGGGCCCGGTCACCGAGGACCCCTCGGCGCCGGTGCCCGGCACCCCGCTGGAGGAGTACTGGCAGACCATGGACGACCTGCGCCGTGAGGGCAAGGTCAGGGCCATCGGGCTGTCCAACCACGGCGTCGACGAGCTGAAGCGGGCCGCCGCCGTCGCGCCGGTCGACGCCGTCCAGCCGCCGTTCTCCGCCCTGGACCGCGGCGCCGCCGACGTCCTCGCCTGGTGCGACGCGCACGGCGTCGGCGCGCTCGTCTACCAGTCGCTCAAGTCCGGGCTGCTCTCCGGCACCTTCTCCGCCGAGCGGGTCGCCGCCCTGCCCCCGACCGACTGGCGCCGCGCCGCACCGGACTTCACCACCGGCCTGGCCGCCAACCTCGCCGTCGCCGAGGTCCTGCGCACCGTCGCCCGACGGCACGGCGCCACGGTCACGGCCGTGGCCGTCGCCTGGGCGCTCGCCTGGCCGGGGGTCGCCGGGGCCATCGTCGGCGCCCGCCGCCCCGGGCAGGTCGCCGACTGGCCGCAGGCGGCGACGCTCCGGCTCACCGCGGCCGACCTCGACGAGATCGCGGACGGCATCCGCGCCCAGGTGCCCGACCCCGGGCCCGTACGTCCCTGA	MTTTPLPVRPLGTTGMDISPVGLGAWSLGGSDWGPQDDADSIATIHRAVATGVNWIDTAAAYGLGHSEEVIGRALAGLPAAERPYLFTKCGVVPDPGGLRKVMTADSVRRELEDSLRRLGVEHIDLYQVHWPGDGRLLAWGPVTEDPSAPVPGTPLEEYWQTMDDLRREGKVRAIGLSNHGVDELKRAAAVAPVDAVQPPFSALDRGAADVLAWCDAHGVGALVYQSLKSGLLSGTFSAERVAALPPTDWRRAAPDFTTGLAANLAVAEVLRTVARRHGATVTAVAVAWALAWPGVAGAIVGARRPGQVADWPQAATLRLTAADLDEIADGIRAQVPDPGPVRP	MENENIIEEQKILNFWKEENIFKKSIDNRKNDNPFVFYDGPPTANGLPHTGHVLGRVIKDLFARYKTMQGFYVERKAGWDTHGLPVELGVEKKLGIKDKNEIEKYGIEKFINECKNSVFMYEKQWREFSELIGYWVDMEKPYKTMDNTYIESIWYILSDFHKKGLLYKGHKVTPYCPSCETSLSSHEVAQGYKEVKDISVILKFPILDSDENFLVWTTTPWSLPGNIALAINAEEIYVKVNYDNEIFIIMESLLQSVFKDEDNIDIVSKHKGKEFVGKEYLAPFPNKSLMNNENSYKVLPADFVTNKDGTGIVHIAPAYGEDDYKLVQENNIPFINVIDSRGKYNQDSPIFKGELAKESDINIIKELTHLNLLFKKEKYEHSYPFCWRCDNPLIYYAMEGWFIKTTAYKNEIKENNQKIEWYPDHIKNGRFGNFLDNMIDWNIGRKRYWGTPLNIWKCSTCSHEFSPKSINDLIQHSIEDIPSDIELHRPYIDNVKCKCQNCGGDMCREEEVIDVWFDSGSMPFAQNHYPFSGPIQNSYPADFIAEGVDQTRGWFYSLLVISTIFKGEAPYKNALSLGHILDSNGQKMSKSKGNVIDPISMIKTYGADSLRWTLVSDSVPWTNKRFSENMVAQSKSRVIDTLKNIFNFYNMYQKIDNYDYTRDTPKQLNLLDNWAISRMNSVIKEVELHLEKYNPTNASRAIGEFINEISNWYIRRSRSRFWSSEMNEDKKSAYFTLRLILINTCKIIAPFTPFTSEEIHLNLTKKSVHLEDFPQAKEEYINLKLEEDMNKVLDIVEKSRSIRNNINIKTKQPLSNMYIYDNNNLDNEFLRKYKDIIKDEINVKKINIVSDLDNFLEYDVKPNFSTLGPKLGKDMKQFQILFKNIKKEEMNKLINDFDKLQKVFDSLGVTIEEKDFIISKIPKKGFSLSSNDSDRLIILDTNLTQELIREGFVRELIRVIQQLRKQQNFNIEERINVVIDIDSDGLLSIKNNINILKENVLINNLKFEKRETMKYFKINQKEIGIQLMSSFTN	33.30	gnl|BL_ORD_ID|4698|hsp_num:0	2271			126	492	mupirocin
BGC0000221.1|Erdacin_17 # 13692 # 14372 # -1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.711	BGC0000221.1|Erdacin_17 	13692	14372	-	Loose	500	28.4906	Rhodococcus fascians cmr	32.22	3002701	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCGCCACCACCCCCGTCCGCCGCGCACGGTTACAGCGGCTCGGCGTCTATCTCGCCGGGTGCGTCGTCTTCGCCGCCGGTGCCACGCTCTTCATCCACTCCGCGTACGGCGTCGACCCCCTCGACACCCTCGCCCTCGGACTCCTCGAGCACGTTCCGCTCACCATCGGCATCGCCCAGGCCCTCGTGGCCGTCGTCTGCATCGCCCTCTGGTCGGTGTGGAACCGGCGCCGCCCCGTCCTCTCGCCCTTCGTCACCTTCCTGCTGTGCGGCAGCCTGATCGACCTCATGCGGCTCACCGACACCTCGGCGCTGCCCCGCCCGGTCCAGCTCGCCATCGGCGTCCTGCTCTGCGCGTACGGCTCGGCTCTCATCATCATGAGCGGCATCGGCATCCGCGCCATGGACCTGGTCGTCATCACCATGACCCAGCGCTGGCGTTGGCCGTTCTGGGTCGCCAAGGCCTCCGTCGAGGCCGTGCTGCTGGCCGTCGGCTGGGTCCTCGGCGGACCGGTCGGCGTCGGCACCCTCTGCTTCCTCGTCTTCGTCGACGGCCTCATCCAGCCCTTCATGGCGTTCAACCGGCGTGCCCTGCGCCTGGAGAACCGCGGCCTGGTCCTGGCCGGTTCGCACGCCGCCGCCCCCGCCCCCAGCGCACGGATCCGAGGTACCGCATGA	MPATTPVRRARLQRLGVYLAGCVVFAAGATLFIHSAYGVDPLDTLALGLLEHVPLTIGIAQALVAVVCIALWSVWNRRRPVLSPFVTFLLCGSLIDLMRLTDTSALPRPVQLAIGVLLCAYGSALIIMSGIGIRAMDLVVITMTQRWRWPFWVAKASVEAVLLAVGWVLGGPVGVGTLCFLVFVDGLIQPFMAFNRRALRLENRGLVLAGSHAAAPAPSARIRGTA	MPFAIYVLGIAVFAQGTSEFMLSGLIPDMAQDLQVSVPTAGLLTSAFAIGMIIGAPLMAIVSMRWQRRRALLTFLITFMVVHVIGALTDSFGVLLVTRIVGALANAGFLAVALGAAMSMVPADMKGRATSVLLGGVTIACVVGVPGGALLGELWGWRASFWEVVLISAPAVAAIMASTPADSPTDSVPNATRELSSLRQRKLQLILVLGALINGATFCSFTYLAPTLTDVAGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLVAGSAALLVGWIVFAITASHPVVTLVMLFVQGTLSFAVGSTLISRVLYVADGAPTLGGSFATAAFNVGAALGPALGGVAIGIGMGYRAPLWTSAALVALAIVIGAATWTRWREPRPALDTVPP	57.80	gnl|BL_ORD_ID|294|hsp_num:0	250			12	267	chloramphenicol
BGC0000221.1|Erdacin_18 # 14481 # 14813 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=9bp;gc_cont=0.694	BGC0000221.1|Erdacin_18 	14481	14813	-	Loose	100	38.1206	FosA8	29.73	3007371	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGACACCTTCCTCCTTCGGGAAGTTCGCCGTGCTCGCCATCAAGACCCGCGACCTTCCGGCCATGACCGCCTTCTACCGCGACGTCCTGGGCCTTGAGCCCAAGGCCGCCGGCGAGACGTTCTCGGCCTTCCACACCGGAGCCGGCGGCGAGCTCGTGCTCTGGAACGACGCGGCCGGCCCCTTCGTCCCCGGATTCGCCGGCGCCGACCTGGAGGCGGCGCGCGAGGCGCTCCTCGACGCGAAGCCGACCGAGATCGAGGACCACCCCGGCGGCAAGCACTTCTACCTCACCGACCCCGACGGCAACACCATCGCCTTCAGCAACGGCTGA	MTPSSFGKFAVLAIKTRDLPAMTAFYRDVLGLEPKAAGETFSAFHTGAGGELVLWNDAAGPFVPGFAGADLEAAREALLDAKPTEIEDHPGGKHFYLTDPDGNTIAFSNG	MLNALNHLTLAVSNLPASITFWRDLLGLRLHAEWHTGAYLTCGDLWLCLSYDETRTFIPPQNSDYTHYAFSVEPEHFDAVAQKLKDAGVTVWKENKSEGASFYFLDPDGHKLELHVGDLAARLAACREKPYAGMVFTSDEA	78.01	gnl|BL_ORD_ID|4906|hsp_num:0	5899			21	351	fosfomycin
BGC0000221.1|Erdacin_20 # 15563 # 15949 # 1 # ID=1_20;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=3bp;gc_cont=0.700	BGC0000221.1|Erdacin_20 	15563	15949	+	Loose	2200	25.7942	rpoB2	34.78	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	TTGAGCGCGAATCGGCCACGTGAGGGGCGCGGGGTGAGGGGCGCCGAGGGCGGCCCCTGCCCCATCACCCCGGTGATCGACCTGGTCTTCGGCCGGTGGACGACCCCGGTCCTGTGGGTGCTCAACCACCACGGAAAGCTGCGCTTCACAGAGGTGCAGAAGCTGCTGCCCGACTGCACCCCCAAGGTGCTGACACAGCGACTGCGCCAGCTGGAGGCGGACGGGCTGGTCACGCGTACGTACTACGCGGAGATGCCGCCGCGCGTCGAGTACGAGTCGACCGAACTCGCCCGCACGCTCATCCCCGTCTTCAACGCCCTCGCCGACTGGTCCGACCAGCACCTGGCCGAGGTGCTCGCCGCCCGAGCGGCCTACCAGGGCGACTGA	MSANRPREGRGVRGAEGGPCPITPVIDLVFGRWTTPVLWVLNHHGKLRFTEVQKLLPDCTPKVLTQRLRQLEADGLVTRTYYAEMPPRVEYESTELARTLIPVFNALADWSDQHLAEVLAARAAYQGD	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	11.02	gnl|BL_ORD_ID|2431|hsp_num:0	2831			2619	2757	rifampin; rifaximin; rifabutin; rifapentine
BGC0000221.1|Erdacin_22 # 16752 # 18065 # 1 # ID=1_22;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=3bp;gc_cont=0.731	BGC0000221.1|Erdacin_22 	16752	18065	+	Loose	600	82.4185	Streptomyces venezuelae rox	30.37	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGCTTACCCGCAAGCGCCCAGGCCGTTCTCGACCGGTCCTCGAGGTGCCCCGGGCACGCTCGTCTCCCCCGGCGGAGTGGAGGAGCGAGCGGTGAGGACCGAAGAAGTCGACGCCTGCGTCGTCGGCGGCGGACCGGGCGGCCTGATGACCGGTCTGCTGCTGGCCCGGCAGGGCGTCCGCGTCACCGTCCTGGAGAAGCACCCCGACTTCCTGCGGGACTTCCGGGGCGACACCGTCCACCCCTCGACGCTCCGCGTCATGGACGAACTCGGCCTGCTCCAGGACTTCCTGAAGATCCCGCACGCCAAGGCCGAGGCCATGACCATGGAGACCGCGATGGGGCCGGCCGTCTTCGCCGACTTCCGCCGGCTCCCCGGCGCGTTCCGGTTCATGGCCTTCATGCCCCAGTGGGACGTGCTCGACTTCCTCGCCGGAGCCGCCCGCGACCTTCCCGGCTTCCGCCTGGAGCAGCGGGCCGAGGTCACCGACGTGATCGAGGAGCGCGGCACGGTCACCGGAGTGGTCGCCAAGACCCCGGACGGGCCGCTCGAAGTGCGGGCGAAGCTCGTCGTCGGCGCCGACGGCAGGCGCTCCGCCGTCCGCGCCTCCGGCGGTCTCGACGTCAAGGGCGACGCCGCGCCGATGGACGCCCTGTGGTTCCGGCTGAGCCGCACCGAGGGCGAGACCGTCCCCACCATCAAAGCCGGCGCCGGCTATCTGGTGGTGTGCATCAACCGGGGCACGTACTGGCAGTCCGTCCAGATGATCCCCAAGGGCGGGTACGAAGCGGTGCGCGCGGCCGGTCTCGACCGGTTCCGCGCCGAAGTGGCCCGCGCTCACCCGGGGTTCGCCGGCCGACTGGCCGAGGAGATCCGCGACTGGGACGACATCAAGCTCCTCGACGTACGGGTCGACCGGCTCCGCCGCTGGTACCGGCCGGGCCTGCTGTGCATCGGGGACGCCGCCCACGCCATGTCCCCGGCCGGCGGGGTCGGCATCAACCTGGCCGTGCAGGACGCCGTCGCCGCGGCCCGGATCCTCGGCCCCGCGCTCCGGGCCGGGCGCGCACCCTCCGAGGCGGAGCTCCGCTCGGTGCAGCGCCGGCGCGAACTGCCGATGCGCGTCATCCAGCTGATGCAGCTGCATCTCCTGGGCGACCTCTATCCGAGCGCCTCCCGCAAGGGCACGGACCGGCCCCTGGTGGTCCGGATGTGCCGGAGGTTCCCCGTCGTGCCGCGCGTCCTCGCCCGGCTGATCGCCCTCGGCATCCGTCCCGAGCCCGTAGGAGGAGCAGCCCGTGTCCGACCGTGA	MAYPQAPRPFSTGPRGAPGTLVSPGGVEERAVRTEEVDACVVGGGPGGLMTGLLLARQGVRVTVLEKHPDFLRDFRGDTVHPSTLRVMDELGLLQDFLKIPHAKAEAMTMETAMGPAVFADFRRLPGAFRFMAFMPQWDVLDFLAGAARDLPGFRLEQRAEVTDVIEERGTVTGVVAKTPDGPLEVRAKLVVGADGRRSAVRASGGLDVKGDAAPMDALWFRLSRTEGETVPTIKAGAGYLVVCINRGTYWQSVQMIPKGGYEAVRAAGLDRFRAEVARAHPGFAGRLAEEIRDWDDIKLLDVRVDRLRRWYRPGLLCIGDAAHAMSPAGGVGINLAVQDAVAAARILGPALRAGRAPSEAELRSVQRRRELPMRVIQLMQLHLLGDLYPSASRKGTDRPLVVRMCRRFPVVPRVLARLIALGIRPEPVGGAARVRP	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	91.81	gnl|BL_ORD_ID|4833|hsp_num:0	5820			6	891	rifampin; rifaximin; rifapentine
BGC0000221.1|Erdacin_24 # 18443 # 19351 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.733	BGC0000221.1|Erdacin_24 	18443	19351	+	Loose	475	57.3806	GMB-1	30.41	3006889	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	GMB beta-lactamase	GTGACCAGCACGACCGGCACGCCACGGCTCGAAGAAGTCGCCGAGCACGTCCACGCCTACATCCAGCCCGACGGCGGGTGGTGTCTGAACAACGCGGGCCTCATCACCGCCGACGGCGACAGCGCGCTCATCGACACCGCCGCCACCGAGCGGCGGGCCCGCGCGCTGCGGGGGGCCGCGCTGACCGTCGGGCCCGCCCCCCGGGTCGTCGTCAACACGCACTCCCACGGCGACCACACCTTCGGCAACTGCCTCTTCCCCGAGGCGGTCGTCGTCGGCCACGCCGGCACCCGCACCGAGATGGAGCAGGTGGGGCTGCACCTCACCGGGCTCTGGCCCGAGGTGTGCTGGGGCGACATCTCCGTGGCACCGCCCACTCTCACGTACGAGAGCCGGCTGACCCTCCATGTCGGCCCGGTCCGCGCCGAGCTGCGGAACATGGGCACCGCCCACACCGTCAACGACACCGTGGTGTGGCTGCCCGAGCAGCGGGTGCTGTTCACCGGCGACCTGGTGATGTCCGGAGTCACCCCGTTCTTCCCCATGGGGTCGCTCTCGGGCTCCCTCGCCGCCATCCGTGAGCTGGCGGCCCTCGACCCCGTCACCGTCGTGACCGGCCACGGCCCGGTCGCCGGTCCCGAGGTGCTGGCGGAGGCCGAGCGGTATCTGCTGTGGATCCGGGAGCTGGCCCAGCAGGGCGAGGAAGCCGGTCTCACCCCTCTGGAGCTGGCCCGCGAGACCGACCCGGCCCCCTGGCTCCACCTCCTGGACCCCGAGCGCCTCGTCCCCAACCTGCACCGCGCCTACGCCGAGCTGCGCGGCGCGGCGCCGGGGTCGCCGATCGACATGGGCGCGCTGTTCCAGGAGATGATCGAGTACCGCGGCGGCGCCCCGGTCTGCCACGCCTGA	MTSTTGTPRLEEVAEHVHAYIQPDGGWCLNNAGLITADGDSALIDTAATERRARALRGAALTVGPAPRVVVNTHSHGDHTFGNCLFPEAVVVGHAGTRTEMEQVGLHLTGLWPEVCWGDISVAPPTLTYESRLTLHVGPVRAELRNMGTAHTVNDTVVWLPEQRVLFTGDLVMSGVTPFFPMGSLSGSLAAIRELAALDPVTVVTGHGPVAGPEVLAEAERYLLWIRELAQQGEEAGLTPLELARETDPAPWLHLLDPERLVPNLHRAYAELRGAAPGSPIDMGALFQEMIEYRGGAPVCHA	MLNFVFALFTAFTAFSAFALDQKAFDEQFAVKELAKDTYQVTDKFYHDSNVLVARMPDGTVVIASSPFETVGAQLMMDWIKEKWDPKRIVAVNTHFHSDGTGGNEAYKQAGAEIWASDLTWRLHRQSTKKDQQALADGFKSKPELRDRILKRKTVHANRTFKSKEGKIFDFGGEKVELIFPGEGHTSDNSVVYLPQRKVLFGGCLIRSAKHDIGYLGDAVVKPWAETVRNVQKLKPEIVIPGHGPVGGPELLTRTIDLAEKEAAKGTTKN	111.85	gnl|BL_ORD_ID|3562|hsp_num:0	4631			255	756	
BGC0000221.1|Erdacin_25 # 19494 # 20027 # 1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.699	BGC0000221.1|Erdacin_25 	19494	20027	+	Loose	900	28.1054	AAC(6')-Ie-APH(2'')-Ia bifunctional protein	22.67	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	aminoglycoside bifunctional resistance protein	ATGACCGAGATCCGTACGCCCCGCCTCATCCTCCGCCGCTGGACCGACGACGACCTCGTCCCGATGGCCGAGATCAACGCGGATCCGGAGGTCATGCGCTGGATCGGGGACGGTTCCGTCCGGGATCTGGAGGAGACCGCCGAGGACATCGAGCGGTGGGAGGAAGAGTGGGACGAGGAGGGCTTCGGGCTCTTCGCCGTCGAGCTCATCGCCTCCGGCGAGCTGATCGGCTTCGCCGGCCTGTCCGTGCCCGAGTTCCTCCCCGAGGTGCTCCCGGCCGTCGAGATCGGCTGGCGGCTCGGACGGCCGTTCTGGGGCCAGGGGTACGCCTCCGAGGCCGCCCACGCGGCGCTGGAGTTCGCCCTTCAGGACCGCGGCCTCGACCGGGTGGTCGGCATCGCCCACATCAGCAACACGGCCTCCGAGAACGTCATGCGCAAGCTCGGCATGTCCCCGGAGCGCGACGTCAACCACCCGGTCTTCGGGGTCCCGCTGCGCGTGTACGCCATCGACCTCACCGAGTACCAGGGCTGA	MTEIRTPRLILRRWTDDDLVPMAEINADPEVMRWIGDGSVRDLEETAEDIERWEEEWDEEGFGLFAVELIASGELIGFAGLSVPEFLPEVLPAVEIGWRLGRPFWGQGYASEAAHAALEFALQDRGLDRVVGIAHISNTASENVMRKLGMSPERDVNHPVFGVPLRVYAIDLTEYQG	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	36.95	gnl|BL_ORD_ID|4823|hsp_num:0	1814			21	459	dibekacin; amikacin; sisomicin; netilmicin; kanamycin A; tobramycin; gentamicin A; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
